ABSTRACT
Cryptococcosis was diagnosed in an immunosuppressed patient. Topical treatment was ineffective and treatment with oral itraconazole was started. The lesion improved. Liver enzymes were monitored and, although their levels were raised before the start of itraconazole therapy, they did not increase further during treatment.
Subject(s)
Cryptococcosis , Dermatomycoses , Hepatitis, Chronic/drug therapy , Immunocompromised Host , Adolescent , Antifungal Agents/therapeutic use , Cellulitis/diagnosis , Cryptococcosis/diagnosis , Cryptococcosis/drug therapy , Cryptococcosis/immunology , Dermatomycoses/diagnosis , Dermatomycoses/drug therapy , Dermatomycoses/immunology , Diagnosis, Differential , Female , Hepatitis, Chronic/immunology , Humans , Immunosuppressive Agents/therapeutic use , Itraconazole/therapeutic useABSTRACT
By using the double pour plate method, Yeasts Extract Agar (YE) which contained a high concentration of chloramphenicol-streptomycin sulfate and cycloheximide,, and by inoculating mice intraperitoneally, we succeed in the isolation of different strains of Coccidicides immitis from 12 samples of the soils collected in the province of San Luis and from 1 of the province of Mendoza (Argentina), a 70% of the samples turned out positive. Identification of the strains was based on macro- and micro-morphology of the colonies, pathogenicity for mice and the capacity to transform in shaked cultures.
